Page last updated: 2024-12-08

1,10-bis(carboxymethylthiodecane)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,10-Bis(carboxymethylthiodecane)

1,10-Bis(carboxymethylthiodecane) is a **synthetic molecule** with the chemical formula C16H30O4S2. It's a **long-chain dicarboxylic acid** with two carboxymethylthio groups attached at the ends of a ten-carbon decane chain.

**Importance in Research:**

This molecule is primarily used in research for its **potential applications in: **

* **Materials Science:**
* **Self-assembly:** It can self-assemble into **ordered structures** due to its long alkyl chain and polar carboxylic acid groups. This allows for the creation of **novel materials** with unique properties, like **nanofibers**, **thin films**, and **supramolecular assemblies**. These materials could find use in various applications, including **electronics**, **catalysis**, and **biomedicine**.
* **Biomedical Research:**
* **Drug delivery:** The molecule's **hydrophobic chain** could potentially be used to **encapsulate hydrophobic drugs** and its **carboxylic acid groups** could be modified for **targeted drug delivery**.
* **Biocompatible materials:** The molecule's **biocompatibility** makes it a potential candidate for use in **biomedical implants**, **tissue engineering**, and **drug delivery systems**.

**Current Research:**

There is ongoing research on the synthesis, characterization, and potential applications of 1,10-Bis(carboxymethylthiodecane). Researchers are exploring its self-assembly properties, its ability to form **nanostructures**, and its potential as a **biocompatible material**.

**Overall:**

1,10-Bis(carboxymethylthiodecane) is a promising molecule with potential applications in various research fields. Its unique properties and ability to self-assemble make it a versatile building block for creating new materials and exploring new technologies.

**Note:** While there is ongoing research, it is important to understand that this molecule is still in the **early stages of development** and its full potential is yet to be realized.

1,10-bis(carboxymethylthiodecane): structure given in first source; alkylthio dicarboxylic acid; non-beta-oxidizable & non-omega-oxidizable [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161757
SCHEMBL ID5597990
MeSH IDM0171965

Synonyms (10)

Synonym
bcmtd
32827-49-9
2-[10-(carboxymethylsulfanyl)decylsulfanyl]acetic acid
3-thiadicarboxylic acid
1,10-bis(carboxymethylthiodecane)
1,10-bis(carboxymethylthio)decane
acetic acid, 2,2'-(1,10-decanediylbis(thio))bis-
SCHEMBL5597990
DTXSID80186497
1,10-bis(carboxy-methylthio)decane

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In a separate dose-response study BCMTD was found to be a more potent inducer of peroxisomal beta-oxidation compared to tiadenol."( The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester.
Aarsaether, N; Aarsland, A; Berge, RK; Bremer, J, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.53)18.7374
1990's17 (89.47)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.31 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]